A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase

Science Signaling

Volumn 7, Issue 356, 2014, Pages

  Low, Teck Yew ^a,b   Peng, Mao ^a,b   Magliozzi, Roberto ^c   Mohammed, Shabaz ^a,b,d   Guardavaccaro, Daniele ^c   Heck, Albert J R ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CUL1 PROTEIN; F BOX PROTEIN; RBX1 PROTEIN; SKP1 PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE SCF; UNCLASSIFIED DRUG; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN;

AFFINITY PURIFICATION MASS SPECTROMETRY; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; ENZYME SUBSTRATE; ENZYME SUBUNIT; HUMAN; MASS SPECTROMETRY; NUCLEOTIDE REPEAT; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RELIABILITY; STRUCTURAL PROTEOMICS; WORKFLOW; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; HEK293 CELL LINE; METABOLISM; PROTEIN MOTIF;

AMINO ACID MOTIFS; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; HEK293 CELLS; HUMANS; SKP CULLIN F-BOX PROTEIN LIGASES; SUBSTRATE SPECIFICITY;

EID: 84919331120     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005882     Document Type: Article

References (98)

1. I. Dikic, S. Wakatsuki, K. J. Walters, Ubiquitin-binding domains-From structures to functions. Nat. Rev. Mol. Cell Biol. 10, 659-671 (2009).
2. M. H. Glickman, A. Ciechanover, The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev. 82, 373-428 (2002).
3. C. M. Pickart, M. J. Eddins, Ubiquitin: Structures, functions, mechanisms. Biochim. Biophys. Acta 1695, 55-72 (2004).
4. C. A. M. Semple; RIKEN GER Group; GSL Members, The comparative proteomics of ubiquitination in mouse. Genome Res. 13, 1389-1394 (2003).
5. A. W. Lau, H. Fukushima, W. Wei, The Fbw7 and beta-TRCP E3 ubiquitin ligases and their roles in tumorigenesis. Front. Biosci. 17, 2197-2212 (2012).
6. S. Lipkowitz, A. M. Weissman, RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 11, 629-643 (2011).
7. R. Fukunaga, T. Hunter, MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921-1933 (1997).
8. C. F. Burande, M. L. Heuzé, I. Lamsoul, B. Monsarrat, S. Uttenweiler-Joseph, P. G. Lutz, A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation. Mol. Cell. Proteomics 8, 1719-1727 (2009).
9. A. Arabi, K. Ullah, R. M. M. Branca, J. Johansson, D. Bandarra, M. Haneklaus, J. Fu, I. Ariës, P. Nilsson, M. L. Den Boer, K. Pokrovskaja, D. Grandér, G. Xiao, S. Rocha, J. Lehtiö, O. Sangfelt, Proteomic screen reveals Fbw7 as a modulator of the NF-kB pathway. Nat. Commun. 3, 976 (2012).
10. B. K. Koo, M. Spit, I. Jordens, T. Y. Low, D. E. Stange, M. van de Wetering, J. H. van Es, S. Mohammed, A. J. R. Heck, M. M. Maurice, H. Clevers, Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488, 665-669 (2012).
11. G. Xu, J. S. Paige, S. R. Jaffrey, Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotechnol. 28, 868-873 (2010).
12. W. Kim, E. J. Bennett, E. L. Huttlin, A. Guo, J. Li, A. Possemato, M. E. Sowa, R. Rad, J. Rush, M. J. Comb, J. W. Harper, S. P. Gygi, Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340 (2011).
13. K. A. Lee, L. P. Hammerle, P. S. Andrews, M. P. Stokes, T. Mustelin, J. C. Silva, R. A. Black, J. R. Doedens, Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J. Biol. Chem. 286, 41530-41538 (2011).
14. A. Peschiaroli, N. V. Dorrello, D. Guardavaccaro, M. Venere, T. Halazonetis, N. E. Sherman, M. Pagano, SCFβTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol. Cell 23, 319-329 (2006).
15. N. V. Dorrello, A. Peschiaroli, D. Guardavaccaro, N. H. Colburn, N. E. Sherman, M. Pagano, S6K1-and bTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467-471 (2006).
16. D. Guardavaccaro, D. Frescas, N. V. Dorrello, A. Peschiaroli, A. S. Multani, T. Cardozo, A. Lasorella, A. Iavarone, S. Chang, E. Hernando, M. Pagano, Control of chromosome stability by the b-TrCP-REST-Mad2 axis. Nature 452, 365-369 (2008).
17. J. W. Harper, M. K. M. Tan, Understanding cullin-RING E3 biology through proteomicsbased substrate identification. Mol. Cell. Proteomics 11, 1541-1550 (2012).
18. E. Dehan, F. Bassermann, D. Guardavaccaro, G. Vasiliver-Shamis, M. Cohen, K. N. Lowes, M. Dustin, D. C. S. Huang, J. Taunton, M. Pagano, βTrCP-and Rsk1/2-mediated degradation of BimEL inhibits apoptosis. Mol. Cell 33, 109-116 (2009).
19. G. Wu, G. Xu, B. A. Schulman, P. D. Jeffrey, J. W. Harper, N. P. Pavletich, Structure of a b-TrCP1-Skp1-b-catenin complex: Destruction motif binding and lysine specificity of the SCFb-TrCP1 ubiquitin ligase. Mol. Cell 11, 1445-1456 (2003).
20. J. T. Winston, P. Strack, P. Beer-Romero, C. Y. Chu, S. J. Elledge, J. W. Harper, The SCFb-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkBa and b-catenin and stimulates IkBa ubiquitination in vitro. Genes Dev. 13, 270-283 (1999).
21. F. Kruiswijk, L. Yuniati, R. Magliozzi, T. Y. Low, R. Lim, R. Bolder, S. Mohammed, C. G. Proud, A. J. R. Heck, M. Pagano, D. Guardavaccaro, Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress. Sci. Signal. 5, ra40 (2012).
22. D. Frescas, M. Pagano, Deregulated proteolysis by the F-box proteins SKP2 and b-TrCP: Tipping the scales of cancer. Nat. Rev. Cancer 8, 438-449 (2008).
23. H. Choi, B. Larsen, Z. Y. Lin, A. Breitkreutz, D. Mellacheruvu, D. Fermin, Z. S. Qin, M. Tyers, A. C. Gingras, A. I. Nesvizhskii, SAINT: Probabilistic scoring of affinity purification-mass spectrometry data. Nat. Methods 8, 70-73 (2011).
24. D. Mellacheruvu, Z. Wright, A. L. Couzens, J. P. Lambert, N. A. St-Denis, T. Li, Y. V. Miteva, S. Hauri, M. E. Sardiu, T. Y. Low, V. A. Halim, R. D. Bagshaw, N. C. Hubner, A. Al-Hakim, A. Bouchard, D. Faubert, D. Fermin,W. H. Dunham, M. Goudreault, Z. Y. Lin, B. G. Badillo, T. Pawson, D. Durocher, B. Coulombe, R. Aebersold, G. Superti-Furga, J. Colinge, A. J. Heck, H. Choi,M. Gstaiger, S.Mohammed, I. M. Cristea, K. L. Bennett, M. P. Washburn, B. Raught, R. M. Ewing, A. C. Gingras, A. I. Nesvizhskii, The CRAPome: A contaminant repository for affinity purification-mass spectrometry data. Nat. Methods 10, 730-736 (2013).
25. H. Choi, T. Glatter, M. Gstaiger, A. I. Nesvizhskii, SAINT-MS1: Protein-protein interaction scoring using label-free intensity data in affinity purification-mass spectrometry experiments. J. Proteome Res. 11, 2619-2624 (2012).
26. H. Choi, G. Liu, D. Mellacheruvu, M. Tyers, A. C. Gingras, A. I. Nesvizhskii, Analyzing protein-protein interactions from affinity purification-mass spectrometry data with SAINT. Curr. Protoc. Bioinformatics Chapter 8, Unit 8.15 (2012).
27. J. Cox, M. Mann, MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
28. J. Cox, I. Matic, M. Hilger, N. Nagaraj, M. Selbach, J. V. Olsen, M. Mann, A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 4, 698-705 (2009).
29. J. Cox, N. Neuhauser, A. Michalski, R. A. Scheltema, J. V. Olsen, M. Mann, Andromeda: A peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
30. N. C. Hubner, M. Mann, Extracting gene function from protein-protein interactions using Quantitative BAC InteraCtomics (QUBIC). Methods 53, 453-459 (2011).
31. L. Trinkle-Mulcahy, J. Andersen, Y. W. Lam, G. Moorhead, M. Mann, A. I. Lamond, Repo-Man recruits PP1g to chromatin and is essential for cell viability. J. Cell Biol. 172, 679-692 (2006).
32. B. Blagoev, I. Kratchmarova, S. E. Ong, M. Nielsen, L. J. Foster, M. Mann, A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 21, 315-318 (2003).
33. I. Kratchmarova, B. Blagoev, M. Haack-Sorensen, M. Kassem, M. Mann, Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308, 1472-1477 (2005).
34. J. A. Ranish, E. C. Yi, D. M. Leslie, S. O. Purvine, D. R. Goodlett, J. Eng, R. Aebersold, The study of macromolecular complexes by quantitative proteomics. Nat. Genet. 33, 349-355 (2003).
35. P. V. Hornbeck, J. M. Kornhauser, S. Tkachev, B. Zhang, E. Skrzypek, B. Murray, V. Latham, M. Sullivan, PhosphoSitePlus: A comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270 (2012).
36. R. Gutman, C. Berezin, R. Wollman, Y. Rosenberg, N. Ben-Tal, QuasiMotiFinder: Protein annotation by searching for evolutionarily conserved motif-like patterns. Nucleic Acids Res. 33, W255-W261 (2005).
37. N. E. Davey, D. C. Shields, R. J. Edwards, Masking residues using context-specific evolutionary conservation significantly improves short linear motif discovery. Bioinformatics 25, 443-450 (2009).
38. M. Peng, A. Scholten, A. J. R. Heck, B. van Breukelen, Identification of enriched PTM crosstalk motifs from large-scale experimental data sets. J. Proteome Res. 13, 249-259 (2014).
39. R. Magliozzi, T. Y. Low, B. G. M. W. Weijts, T. Cheng, E. Spanjaard, S. Mohammed, A. van Veen, H. Ovaa, J. de Rooij, F. J. T. Zwartkruis, J. L. Bos, A. de Bruin, A. J. R. Heck, D. Guardavaccaro, Control of epithelial cell migration and invasion by the IKKb-and CK1a-mediated degradation of RAPGEF2. Dev. Cell 27, 574-585 (2013).
40. S. D'Annibale, J. Kim, R.Magliozzi, T. Y. Low, S. Mohammed,A. J. R. Heck, D. Guardavaccaro, Proteasome-dependent degradation of transcription factor activating enhancer-binding protein 4 (TFAP4) controls mitotic division. J. Biol. Chem. 289, 7730-7737 (2014).
41. A. Yaron, A. Hatzubai, M. Davis, I. Lavon, S. Amit, A. M. Manning, J. S. Andersen, M. Mann, F. Mercurio, Y. Ben-Neriah, Identification of the receptor component of the IkBa-ubiquitin ligase. Nature 396, 590-594 (1998).
42. F. Margottin, S. P. Bour, H. Durand, L. Selig, S. Benichou, V. Richard, D. Thomas, K. Strebel, R. Benarous, A novel human WD protein, h-βTrCP, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565-574 (1998).
43. J. Cox, M. Mann, 1D and 2D annotation enrichment: A statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics 13 (Suppl. 1), S12 (2012).
44. J. Cox, M. Y. Hein, C. A. Luber, I. Paron, N. Nagaraj, M. Mann, MaxLFQ allows accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction. Mol. Cell. Proteomics 13, 2513-2526 (2014).
45. J. Kim, S. D'Annibale, R. Magliozzi, T. Y. Low, P. Jansen, I. A. Shaltiel, S. Mohammed, A. J. R. Heck, R. H. Medema, D. Guardavaccaro, USP17-and SCFβTrCP-regulated degradation of DEC1 controls the DNA damage response. Mol. Cell. Biol. 34, 4177-4185 (2014).
46. J. de Rooij, N. M. Boenink, M. van Triest, R. H. Cool, A. Wittinghofer, J. L. Bos, PDZGEF1, a guanine nucleotide exchange factor specific for Rap1 and Rap2. J. Biol. Chem. 274, 38125-38130 (1999).
47. Y. Liao, K. Kariya, C. D. Hu, M. Shibatohge, M. Goshima, T. Okada, Y. Watari, X. Gao, T. G. Jin, Y. Yamawaki-Kataoka, T. Kataoka, RA-GEF, a novel Rap1A guanine nucleotide exchange factor containing a Ras/Rap1A-associating domain, is conserved between nematode and humans. J. Biol. Chem. 274, 37815-37820 (1999).
48. T. Ohtsuka, Y. Hata, N. Ide, T. Yasuda, E. Inoue, T. Inoue, A. Mizoguchi, Y. Takai, nRap GEP: A novel neural GDP/GTP exchange protein for Rap1 small G protein that interacts with synaptic scaffolding molecule (S-SCAM). Biochem. Biophys. Res. Commun. 265, 38-44 (1999).
49. M. Larance, G. Ramm, J. Stöckli, E. M. van Dam, S. Winata, V. Wasinger, F. Simpson, M. Graham, J. R. Junutula, M. Guilhaus, D. E. James, Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J. Biol. Chem. 280, 37803-37813 (2005).
50. C. P. Mîinea, H. Sano, S. Kane, E. Sano,M. Fukuda, J. Peränen, W. S. Lane, G. E. Lienhard, AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPaseactivating protein domain. Biochem. J. 391, 87-93 (2005).
51. D. L. Swaney, G. C. McAlister, J. J. Coon, Decision tree-driven tandem mass spectrometry for shotgun proteomics. Nat. Methods 5, 959-964 (2008).
52. C. K. Frese, A. F. M. Altelaar, M. L. Hennrich, D. Nolting, M. Zeller, J. Griep-Raming, A. J. R. Heck, S. Mohammed, Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos. J. Proteome Res. 10, 2377-2388 (2011).
53. N. C. Hubner, A. W. Bird, J. Cox, B. Splettstoesser, P. Bandilla, I. Poser, A. Hyman, M. Mann, Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions. J. Cell Biol. 189, 739-754 (2010).
54. T. L. Bailey, M. Boden, F. A. Buske, M. Frith, C. E. Grant, L. Clementi, J. Ren, W. W. Li, W. S. Noble, MEME SUITE: Tools for motif discovery and searching. Nucleic Acids Res. 37, W202-W208 (2009).
55. T. L. Bailey, C. Elkan, Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28-36 (1994).
56. C. E. Grant, T. L. Bailey, W. S. Noble, FIMO: Scanning for occurrences of a given motif. Bioinformatics 27, 1017-1018 (2011).
57. L. J. Jensen, P. Julien, M. Kuhn, C. von Mering, J. Muller, T. Doerks, P. Bork, eggNOG: Automated construction and annotation of orthologous groups of genes. Nucleic Acids Res. 36, D250-D254 (2008).
58. Y. Li, K. G. Suresh Kumar, W. Tang, V. S. Spiegelman, S. Y. Fuchs, Negative regulation of prolactin receptor stability and signaling mediated by SCFb-TrCP E3 ubiquitin ligase. Mol. Cell. Biol. 24, 4038-4048 (2004).
59. B. P. Zhou, J. Deng, W. Xia, J. Xu, Y. M. Li, M. Gunduz, M. C. Hung, Dual regulation of Snail by GSK-3b-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931-940 (2004).
60. I. Lassot, E. Ségéral, C. Berlioz-Torrent, H. Durand, L. Groussin, T. Hai, R. Benarous, F. Margottin-Goguet, ATF4 degradation relies on a phosphorylation-dependent interaction with the SCFβTrCP ubiquitin ligase. Mol. Cell. Biol. 21, 2192-2202 (2001).
61. J. Pons, N. Evrard-Todeschi, G. Bertho, J. Gharbi-Benarous, V. Tanchou, R. Benarous, J. P. Girault, Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase b-TrCP. Competition STD-NMR with b-catenin. Biochemistry 47, 14-29 (2008).
62. H. Chen, H. Ma, H. Inuzuka, J. Diao, F. Lan, Y. G. Shi, W. Wei, Y. Shi, DNA damage regulates UHRF1 stability via the SCFb-TrCP E3 ligase. Mol. Cell. Biol. 33, 1139-1148 (2013).
63. D. V. Hansen, A. V. Loktev, K. H. Ban, P. K. Jackson, Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFβTrCP-dependent destruction of the APC Inhibitor Emi1. Mol. Biol. Cell 15, 5623-5634 (2004).
64. J. Jin, T. Shirogane, L. Xu, G. Nalepa, J. Qin, S. J. Elledge, J. W. Harper, SCFb-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17, 3062-3074 (2003).
65. R. E. Amir, H. Haecker, M. Karin, A. Ciechanover, Mechanism of processing of the NF-kB2 p100 precursor: Identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFb-TrCP ubiquitin ligase. Oncogene 23, 2540-2547 (2004).
66. Y. Kee, J. M. Kim, A. D. D'Andrea, Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. Genes Dev. 23, 555-560 (2009).
67. B. Zhao, L. Li, K. Tumaneng, C. Y. Wang, K. L. Guan, A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFb-TRCP. Genes Dev. 24, 72-85 (2010).
68. T. Shirogane, J. Jin, X. L. Ang, J. W. Harper, SCFb-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein. J. Biol. Chem. 280, 26863-26872 (2005).
69. S. Chowdhry, Y. Zhang, M. McMahon, C. Sutherland, A. Cuadrado, J. D. Hayes, Nrf2 is controlled by two distinct b-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32, 3765-3781 (2013).
70. M. Hayakawa, H. Kitagawa, K. Miyazawa, M. Kitagawa, K. Kikugawa, The FWD1/b-TrCPmediated degradation pathway establishes a "turning off switch" of a Cdc42 guanine nucleotide exchange factor, FGD1. Genes Cells 10, 241-251 (2005).
71. K. Ohsaki, K. Oishi, Y. Kozono, K. Nakayama, K. I. Nakayama, N. Ishida, The role of b-TrCP1 and b-TrCP2 in circadian rhythm generation by mediating degradation of clock protein PER2. J. Biochem. 144, 609-618 (2008).
72. S. Reischl, K. Vanselow, P. O.Westermark, N. Thierfelder, B. Maier, H. Herzel, A. Kramer, b-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics. J. Biol. Rhythms 22, 375-386 (2007).
73. A. C. da Silva Almeida, G. J. Strous, A. G. S. H. van Rossum, βTrCP controls GH receptor degradation via two different motifs. Mol. Endocrinol. 26, 165-177 (2012).
74. Y. Zhao, X. Xiong, Y. Sun, DEPTOR, an mTOR inhibitor, is a physiological substrate of SCFβTrCP E3 ubiquitin ligase and regulates survival and autophagy. Mol. Cell 44, 304-316 (2011).
75. A. C. Burrows, J. Prokop, M. K. Summers, Skp1-Cul1-F-box ubiquitin ligase (SCFβTrCP)-mediated destruction of the ubiquitin-specific protease USP37 during G2-phase promotes mitotic entry. J. Biol. Chem. 287, 39021-39029 (2012).
76. K. G. S. Kumar, W. Tang, A. K. Ravindranath, W. A. Clark, E. Croze, S. Y. Fuchs, SCFHOS ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-a receptor. EMBO J. 22, 5480-5490 (2003).
77. N. Watanabe, H. Arai, Y. Nishihara, M. Taniguchi, N. Watanabe, T. Hunter, H. Osada, M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFb-TrCP. Proc. Natl. Acad. Sci. U.S.A. 101, 4419-4424 (2004).
78. S. Wei, H. C. Chuang, W. C. Tsai, H. C. Yang, S. R. Ho, A. J. Paterson, S. K. Kulp, C. S. Chen, Thiazolidinediones mimic glucose starvation in facilitating Sp1 degradation through the upregulation of b-transducin repeat-containing protein. Mol. Pharmacol. 76, 47-57 (2009).
79. S.Hatakeyama, M. Kitagawa, K. Nakayama, M. Shirane, M. Matsumoto, K. Hattori, H. Higashi, H. Nakano, K. Okumura, K. Onoé, R. A. Good, Ubiquitin-dependent degradation of IkBa is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc. Natl. Acad. Sci. U.S.A. 96, 3859-3863 (1999).
80. A. Seki, J. A. Coppinger, H. Du, C. Y. Jang, J. R. Yates III, G. Fang, Plk1-and b-TrCP-dependent degradation of Bora controls mitotic progression. J. Cell Biol. 181, 65-78 (2008).
81. W. Huang, X. Lv, C. Liu, Z. Zha, H. Zhang, Y. Jiang, Y. Xiong, Q. Y. Lei, K. L. Guan, The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFb-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J. Biol. Chem. 287, 26245-26253 (2012).
82. C. Y. Liu, Z. Y. Zha, X. Zhou, H. Zhang, W. Huang, D. Zhao, T. Li, S. W. Chan, C. J. Lim, W. Hong, S. Zhao, Y. Xiong, Q. Y. Lei, K. L. Guan, The Hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFb-TrCP E3 ligase. J. Biol. Chem. 285, 37159-37169 (2010).
83. L. Meyer, B. Deau, H. Forejtníková, D. Duménil, F.Margottin-Goguet, C. Lacombe, P. Mayeux, F. Verdier, b-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 109, 5215-5222 (2007).
84. V. Lang, J. Janzen, G. Z. Fischer, Y. Soneji, S. Beinke, A. Salmeron, H. Allen, R. T. Hay, Y. Ben-Neriah, S. C. Ley, βTrCP-mediated proteolysis of NF-kB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol. Cell. Biol. 23, 402-413 (2003).
85. F. Mantovani, L. Banks, Regulation of the discs large tumor suppressor by a phosphorylationdependent interaction with the b-TrCP ubiquitin ligase receptor. J. Biol. Chem. 278, 42477-42486 (2003).
86. D. Setoyama, M. Yamashita, N. Sagata, Mechanism of degradation of CPEB during Xenopus oocyte maturation. Proc. Natl. Acad. Sci. U.S.A. 104, 18001-18006 (2007).
87. X. L. Ang, D. P. Seeburg, M. Sheng, J. W. Harper, Regulation of postsynaptic RapGAP SPAR by Polo-like kinase 2 and the SCFb-TRCP ubiquitin ligase in hippocampal neurons. J. Biol. Chem. 283, 29424-29432 (2008).
88. G. Guderian, J. Westendorf, A. Uldschmid, E. A. Nigg, Plk4 trans-autophosphorylation regulates centriole number by controlling βTrCP-mediated degradation. J. Cell Sci. 123, 2163-2169 (2010).
89. H. Fukushima, K. Ogura, L.Wan, Y. Lu, V. Li, D. Gao, P. Liu, A.W. Lau, T.Wu,M.W. Kirschner, H. Inuzuka, W. Wei, SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression. Cell Rep. 4, 803-816 (2013).
90. N. Popov, C. Schülein, L. A. Jaenicke, M. Eilers, Ubiquitylation of the amino terminus of Myc by SCFb-TrCP antagonizes SCFFbw7-mediated turnover. Nat. Cell Biol. 12, 973-981 (2010).
91. M. L. Li, J. Defren, G. Brewer, Hsp27 and F-box protein b-TrCP promote degradation of mRNA decay factor AUF1. Mol. Cell. Biol. 33, 2315-2326 (2013).
92. Y. Kanemori, K. Uto, N. Sagata, b-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc. Natl. Acad. Sci. U.S.A. 102, 6279-6284 (2005).
93. H. Inuzuka, A. Tseng, D. Gao, B. Zhai, Q. Zhang, S. Shaik, L. Wan, X. L. Ang, C. Mock, H. Yin, J. M. Stommel, S. Gygi, G. Lahav, J. Asara, Z. X. J. Xiao,W. G. Kaelin, J.W. Harper, W.Wei, Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCFb-TRCP ubiquitin ligase. Cancer Cell 18, 147-159 (2010).
94. J. Zhong, K. Ogura, Z. Wang, H. Inuzuka, Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis. Discov. Med. 15, 7-15 (2013).
95. Q. Ding, X. He, J. M. Hsu, W. Xia, C. T. Chen, L. Y. Li, D. F. Lee, J. C. Liu, Q. Zhong, X. Wang, M. C. Hung, Degradation of Mcl-1 by b-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol. Cell. Biol. 27, 4006-4017 (2007).
96. P. C. Chu, H. C. Chuang, S. K. Kulp, C. S. Chen, The mRNA-stabilizing factor HuR protein is targeted by b-TrCP protein for degradation in response to glycolysis inhibition. J. Biol. Chem. 287, 43639-43650 (2012).
97. E. Estrabaud, I. Lassot, G. Blot, E. Le Rouzic, V. Tanchou, E. Quemeneur, L. Daviet, F. Margottin-Goguet, R. Benarous, RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of b-catenin by interacting with βTrCP. Cancer Res. 67, 1054-1061 (2007).
98. G. Coadou, J. Gharbi-Benarous, S. Megy, G. Bertho, N. Evrard-Todeschi, E. Segeral, R. Benarous, J. P. Girault, NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein b-TrCP. Biochemistry 42, 14741-14751 (2003).